Overcoming Drug Resistance in Cancer Cells
Author Information
Author(s): C. Gaveriaux, D. Boesch, J.J. Boelsterli, P. Bollinger, M.K. Eberle, P. Hiestand, T. Payne, R. Traber, R. Wenger, F. Loor
Primary Institution: Preclinical Research Department, Sandoz, Basel, Switzerland
Hypothesis
Can cyclosporin A and its derivatives increase the susceptibility of multidrug-resistant cancer cells to chemotherapy?
Conclusion
Cyclosporin A and some of its derivatives can significantly increase the sensitivity of multidrug-resistant cancer cells to certain anti-tumor drugs.
Supporting Evidence
- Cyclosporin A increased the in vitro susceptibility of both parental and multidrug-resistant CHO cell lines to anti-tumor drugs.
- The largest gains in sensitivity were observed in multidrug-resistant cells.
- Some derivatives of cyclosporin were found to be non-immunosuppressive yet effective in reversing drug resistance.
Takeaway
This study found that a drug called cyclosporin A can help cancer cells that are usually resistant to treatment become more sensitive to chemotherapy.
Methodology
The study used Chinese hamster ovary (CHO) cell lines to test the effects of cyclosporin A and its derivatives on drug resistance to colchicine, daunomycin, and vincristine.
Limitations
The study primarily focused on in vitro models, which may not fully represent in vivo conditions.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website